摘要
胰腺癌是一种高致死性、难治性消化道肿瘤,起病隐匿、有效治疗手段少、早期复发转移为其主要临床特征。随着现代诊疗技术及生物医学工程的不断发展,各种治疗方案、诊疗模式不断更新。多学科综合治疗(multi-disciplinary treatment,MDT)的治疗模式广泛应用于临床,为病人制定出规范化、系统化、个体化治疗方案,延长了病人的生存时间,提高了生活质量,取得了不错的临床疗效。该文根据重庆市人民医院肝胆胰腺外科的MDT诊疗经验,对如何改善胰腺癌MDT诊疗模式提出建议,并结合作者单位的经验,对在胰腺癌MDT诊疗中的关键点做出阐述,以期提高胰腺癌病人的临床获益。
Pancreatic cancer is a highly lethal and refractory malignant tumor,characterized by insidious onset,lack of effective treatments,and early recurrence and metastasis.With the development of modern diagnostic and therapeutic technology and biomedical engineering,various therapeutic models are constantly updated.multi-disciplinary treatment(MDT)model is widely used in clinical practice,formulating standardized,systematic and individualized treatment plans for patients.It contributes to prolong the overall survival time and improvequality of life for pancreatic cancer patient,as well achievegood clinical efficacy.Based on the experience of our center,this article explores that how to improve the efficacy of MDT in pancreatic cancer.The key points are described in order to enhance the clinical benefit for pancreatic cancer patients.
作者
杨永君
郭诗翔
王槐志
Yang Yongjun;Guo Shixiang;Wang Huaizhi(Institute of Hepatopancreatobiliary Surgery,Chongqing General Hospital,Chongqing 401147,China;Chongqing School,University of Chinese Academy of Sciences,Chongqing 400714,China)
出处
《腹部外科》
2022年第5期305-308,共4页
Journal of Abdominal Surgery
基金
重庆市科卫联合医学科研项目(2021MSXM344)
重庆市渝中区自然科学基金(20210160)
重庆市自然科学基金面上项目(cstc2020jcyj-msxmX0707)。
关键词
胰腺癌
手术治疗
同质化
多学科综合治疗
糖类抗原19-9
Pancreatic cancer
Surgical treatment
Homogenization
Multi-disciplinary treatment
Carbohydrate antigen 19-9